{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:02:54Z","timestamp":1791525774451,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"DOI":"10.1007\/s00784-024-05935-5","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T02:10:10Z","timestamp":1727230210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of botulinum neurotoxin A in persistent idiopathic dentoalveolar pain: a case series"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6150-9439","authenticated-orcid":false,"given":"Katia","family":"Rupel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Martina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottaviani","family":"Giulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di Lenarda","family":"Roberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manganotti","family":"Paolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizzo","family":"Roberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,25]]},"reference":[{"issue":"13","key":"5935_CR1","doi-asserted-by":"publisher","first-page":"7112","DOI":"10.3390\/ijms22137112","volume":"22","author":"BJ Sessle","year":"2021","unstructured":"Sessle BJ (2021) Chronic Orofacial Pain: models, mechanisms, and genetic and related environmental influences. Int J Mol Sci 22(13):7112. https:\/\/doi.org\/10.3390\/ijms22137112","journal-title":"Int J Mol Sci"},{"issue":"12","key":"5935_CR2","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.3390\/biomedicines11123266","volume":"11","author":"F Canfora","year":"2023","unstructured":"Canfora F, Ottaviani G, Calabria E, Pecoraro G, Leuci S, Coppola N, Sansone M, Rupel K, Biasotto M, Di Lenarda R, Mignogna MD, Adamo D (2023) Advancements in understanding and classifying chronic Orofacial Pain: key insights from Biopsychosocial Models and International classifications (ICHD-3, ICD-11, ICOP). Biomedicines 11(12):3266. https:\/\/doi.org\/10.3390\/biomedicines11123266","journal-title":"Biomedicines"},{"key":"5935_CR3","doi-asserted-by":"publisher","unstructured":"International Classification of Orofacial Pain, 1st edition, ICOP (2020) () Cephalalgia 40(2):129\u2013221. https:\/\/doi.org\/10.1177\/0333102419893823","DOI":"10.1177\/0333102419893823"},{"issue":"10","key":"5935_CR4","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1046\/j.1526-4610.2003.03207.x","volume":"43","author":"M Melis","year":"2003","unstructured":"Melis M, Lobo SL, Ceneviz C, Zawawi K, Al-Badawi E, Maloney G, Mehta N (2003) Atypical odontalgia: a review of the literature. Headache 43(10):1060\u20131074. https:\/\/doi.org\/10.1046\/j.1526-4610.2003.03207.x","journal-title":"Headache"},{"key":"5935_CR5","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.2147\/JPR.S379430","volume":"15","author":"Z Jia","year":"2022","unstructured":"Jia Z, Yu J, Zhao C, Ren H, Luo F (2022) Outcomes and predictors of response of Duloxetine for the treatment of Persistent Idiopathic Dentoalveolar Pain: a retrospective Multicenter Observational Study. J Pain Res 15:3031\u20133041. https:\/\/doi.org\/10.2147\/JPR.S379430","journal-title":"J Pain Res"},{"issue":"1","key":"5935_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/s1079-2104(98)90393-6","volume":"85","author":"ER Vickers","year":"1998","unstructured":"Vickers ER, Cousins MJ, Walker S, Chisholm K (1998) Analysis of 50 patients with atypical odontalgia. A preliminary report on pharmacological procedures for diagnosis and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85(1):24\u201332. https:\/\/doi.org\/10.1016\/s1079-2104(98)90393-6","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"5935_CR7","doi-asserted-by":"crossref","unstructured":"Porporatti AL, Costa YM, Stuginski-Barbosa J, Bonjardim LR, Conti PC, Svensson P (2015)Quantitative methods for somatosensory evaluation in atypical odontalgia. Braz Oral Res 29:S1806-83242015000100400. doi: 10.1590\/1807-3107BOR-2015.vol29.0020","DOI":"10.1590\/1807-3107BOR-2015.vol29.0020"},{"issue":"2","key":"5935_CR8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.joen.2017.09.009","volume":"44","author":"A Malacarne","year":"2018","unstructured":"Malacarne A, Spierings ELH, Lu C, Maloney GE (2018) Persistent Dentoalveolar Pain Disorder: a Comprehensive Review. J Endod 44(2):206\u2013211. https:\/\/doi.org\/10.1016\/j.joen.2017.09.009","journal-title":"J Endod"},{"issue":"3","key":"5935_CR9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.pain.2006.02.005","volume":"122","author":"T List","year":"2006","unstructured":"List T, Leijon G, Helkimo M, \u00d6ster A, Svensson P (2006) Effect of local anesthesia on atypical odontalgia\u2013a randomized controlled trial. Pain 122(3):306\u2013314. https:\/\/doi.org\/10.1016\/j.pain.2006.02.005","journal-title":"Pain"},{"issue":"S1","key":"5935_CR10","doi-asserted-by":"publisher","first-page":"e32376","DOI":"10.1097\/MD.0000000000032376","volume":"102","author":"A Esquenazi","year":"2023","unstructured":"[10] Esquenazi A, Jost WH, Turkel CC, Wein T, Dimitrova R (2023) Treatment of adult spasticity with Botox (onabotulinumtoxinA): development, insights, and impact. Med (Baltim) 102(S1):e32376. https:\/\/doi.org\/10.1097\/MD.0000000000032376","journal-title":"Med (Baltim)"},{"key":"5935_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/B978-0-12-823357-3.00007-0","volume":"199","author":"V Gonz\u00e1lez-Quintanilla","year":"2024","unstructured":"Gonz\u00e1lez-Quintanilla V, Evers S, Pascual J (2024) OnabotulinumtoxinA: discussion of the evidence for effectiveness of OnabotulinumA and its place in chronic migraine treatment. Handb Clin Neurol 199:87\u2013106. https:\/\/doi.org\/10.1016\/B978-0-12-823357-3.00007-0","journal-title":"Handb Clin Neurol"},{"key":"5935_CR12","doi-asserted-by":"publisher","first-page":"770397","DOI":"10.3389\/fpain.2022.770397","volume":"3","author":"M Deodato","year":"2022","unstructured":"Deodato M, Granato A, Ceschin M, Galmonte A, Manganotti P (2022) Algometer Assessment of pressure Pain threshold after Onabotulinumtoxin-A and physical therapy treatments in patients with chronic migraine: an observational study. Front Pain Res (Lausanne) 3:770397. https:\/\/doi.org\/10.3389\/fpain.2022.770397","journal-title":"Front Pain Res (Lausanne)"},{"key":"5935_CR13","doi-asserted-by":"publisher","unstructured":"Hu X, Xia Y, Li J, Wang X, Liu H, Hu J, Bi J, Wu J, Wang T, Lin Z, Xiong N (2024) Efficacy and safety of Botulinum Toxin Type A in the treatment of trigeminal neuralgia: an update systematic review with meta-analyses. Clin J Pain Feb 22. https:\/\/doi.org\/10.1097\/AJP.0000000000001207","DOI":"10.1097\/AJP.0000000000001207"},{"issue":"5","key":"5935_CR14","first-page":"608","volume":"46","author":"XD Ding","year":"2017","unstructured":"Ding XD, Zhong J, Liu YP, Chen HX (2017) Botulinum as a toxin for treating post-herpetic Neuralgia. Iran J Public Health 46(5):608\u2013611","journal-title":"Iran J Public Health"},{"key":"5935_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.toxicon.2013.05.011","volume":"71","author":"BL Guo","year":"2013","unstructured":"Guo BL, Zheng CX, Sui BD, Li YQ, Wang YY, Yang YL (2013) A closer look to botulinum neurotoxin type A-induced analgesia. Toxicon 71:134\u2013139. https:\/\/doi.org\/10.1016\/j.toxicon.2013.05.011","journal-title":"Toxicon"},{"issue":"8","key":"5935_CR16","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.3390\/toxins7083127","volume":"7","author":"HM Oh","year":"2015","unstructured":"Oh HM, Chung ME (2015) Botulinum Toxin for Neuropathic Pain: a review of the literature. Toxins (Basel) 7(8):3127\u20133154. https:\/\/doi.org\/10.3390\/toxins7083127","journal-title":"Toxins (Basel)"},{"key":"5935_CR17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.neuroscience.2010.11.040","volume":"175","author":"J Mika","year":"2011","unstructured":"Mika J, Rojewska E, Makuch W, Korostynski M, Luvisetto S, Marinelli S, Pavone F, Przewlocka B (2011) The effect of botulinum neurotoxin A on sciatic nerve injury-induced neuroimmunological changes in rat dorsal root ganglia and spinal cord. Neuroscience 175:358\u2013366","journal-title":"Neuroscience"},{"key":"5935_CR18","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S1474-4422(14)70102-4","volume":"13","author":"TS Jensen","year":"2014","unstructured":"Jensen TS, Finnerup NB (2014) Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. Lancet Neurol 13:924\u2013935","journal-title":"Lancet Neurol"},{"issue":"9","key":"5935_CR19","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/joor.13053","volume":"47","author":"A Dawson","year":"2020","unstructured":"Dawson A, Dawson J, Ernberg M (2020) The effect of botulinum toxin A on patients with persistent idiopathic dentoalveolar pain-A systematic review. J Oral Rehabil 47(9):1184\u20131191. https:\/\/doi.org\/10.1111\/joor.13053","journal-title":"J Oral Rehabil"},{"issue":"9186","key":"5935_CR20","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/s0140-6736(99)03057-3","volume":"354","author":"AM Elliott","year":"1999","unstructured":"Elliott AM, Smith BH, Penny KI, Smith WC, Chambers WA (1999) The epidemiology of chronic pain in the community. Lancet 354(9186):1248\u20131252. https:\/\/doi.org\/10.1016\/s0140-6736(99)03057-3","journal-title":"Lancet"},{"issue":"7","key":"5935_CR21","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1097\/j.pain.0000000000000542","volume":"157","author":"L Rayner","year":"2016","unstructured":"Rayner L, Hotopf M, Petkova H, Matcham F, Simpson A, McCracken LM (2016) Depression in patients with chronic pain attending a specialised pain treatment centre: prevalence and impact on health care costs. Pain 157(7):1472\u20131479. https:\/\/doi.org\/10.1097\/j.pain.0000000000000542","journal-title":"Pain"},{"issue":"6","key":"5935_CR22","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/fampra\/cmx034","volume":"34","author":"K Kawai","year":"2017","unstructured":"Kawai K, Kawai AT, Wollan P, Yawn BP (2017) Adverse impacts of chronic pain on health-related quality of life, work productivity, depression and anxiety in a community-based study. Fam Pract 34(6):656\u2013661. https:\/\/doi.org\/10.1093\/fampra\/cmx034","journal-title":"Fam Pract"},{"issue":"1","key":"5935_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/toxins15010059","volume":"15","author":"C Baraldi","year":"2023","unstructured":"Baraldi C, Lo Castro F, Ornello R, Sacco S, Pani L, Guerzoni S (2023) OnabotulinumtoxinA: still the Present for Chronic Migraine. Toxins (Basel) 15(1):59. https:\/\/doi.org\/10.3390\/toxins15010059","journal-title":"Toxins (Basel)"},{"issue":"5","key":"5935_CR24","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/head.13074","volume":"57","author":"AM Blumenfeld","year":"2017","unstructured":"Blumenfeld AM, Silberstein SD, Dodick DW, Aurora SK, Brin MF, Binder WJ (2017) Insights into the functional anatomy behind the PREEMPT injection paradigm: Guidance on achieving optimal outcomes. Headache 57(5):766\u2013777. https:\/\/doi.org\/10.1111\/head.13074","journal-title":"Headache"},{"issue":"6","key":"5935_CR25","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/head.13843","volume":"60","author":"L Pellesi","year":"2020","unstructured":"Pellesi L, Do TP, Ashina H, Ashina M, Burstein R (2020) Dual therapy with Anti-CGRP monoclonal antibodies and Botulinum Toxin for Migraine Prevention: is there a Rationale? Headache 60(6):1056\u20131065. https:\/\/doi.org\/10.1111\/head.13843","journal-title":"Headache"},{"issue":"7","key":"5935_CR26","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/head.13849","volume":"60","author":"R Burstein","year":"2020","unstructured":"Burstein R, Blumenfeld AM, Silberstein SD, Manack Adams A, Brin MF (2020) Mechanism of action of OnabotulinumtoxinA in chronic migraine: a narrative review. Headache 60(7):1259\u20131272. https:\/\/doi.org\/10.1111\/head.13849","journal-title":"Headache"},{"key":"5935_CR27","doi-asserted-by":"publisher","unstructured":"Chaurand J, God\u00ednez-Victoria M, Tellez-Gir\u00f3n A, Facio-Uma\u00f1a JA, Jimenez-Ponce F Incobotulinum toxin type A for treatment of chronic myofascial pain. J Oral Sci 63(1):37\u201340. https:\/\/doi.org\/10.2334\/josnusd.20-0090","DOI":"10.2334\/josnusd.20-0090"},{"issue":"2","key":"5935_CR28","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1179\/crn.2008.017","volume":"26","author":"L Guarda-Nardini","year":"2008","unstructured":"Guarda-Nardini L, Manfredini D, Salamone M, Salmaso L, Tonello S, Ferronato G (2008) Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. Cranio 26(2):126\u2013135. https:\/\/doi.org\/10.1179\/crn.2008.017","journal-title":"Cranio"},{"issue":"2","key":"5935_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.17219\/dmp\/145759","volume":"59","author":"RM Ramos-Herrada","year":"2022","unstructured":"Ramos-Herrada RM, Arriola-Guill\u00e9n LE, Atoche-Socola KJ, Bellini-Pereira SA, Castillo AA (2022) Effects of botulinum toxin in patients with myofascial pain related to temporomandibular joint disorders: a systematic review. Dent Med Probl 59(2):271\u2013280. https:\/\/doi.org\/10.17219\/dmp\/145759","journal-title":"Dent Med Probl"},{"key":"5935_CR30","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.2147\/JPR.S169701","volume":"11","author":"R Garc\u00eda-S\u00e1ez","year":"2018","unstructured":"Garc\u00eda-S\u00e1ez R, Guti\u00e9rrez-Viedma \u00c1, Gonz\u00e1lez-Garc\u00eda N, G\u00f3mez-Mayordomo V, Porta-Etessam J, Cuadrado ML (2018) OnabotulinumtoxinA injections for atypical odontalgia: an open-label study on nine patients. J Pain Res 11:1583\u20131588. https:\/\/doi.org\/10.2147\/JPR.S169701","journal-title":"J Pain Res"},{"issue":"9","key":"5935_CR31","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1093\/pm\/pnw040","volume":"17","author":"ML Cuadrado","year":"2016","unstructured":"Cuadrado ML, Garc\u00eda-Moreno H, Arias JA, Pareja JA (2016) Botulinum Neurotoxin Type-A for the treatment of atypical Odontalgia. Pain Med 17(9):1717\u20131721. https:\/\/doi.org\/10.1093\/pm\/pnw040","journal-title":"Pain Med"},{"issue":"2","key":"5935_CR32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.11607\/ofph.2031","volume":"33","author":"I Moreno-Hay","year":"2019","unstructured":"Moreno-Hay I, Mishra P, Okeson JP (2019) Intraoral Administration of Botulinum Toxin for continuous Dentoalveolar Neuropathic Pain: a Case Series. J Oral Facial Pain Headache 33(2):160\u2013164. https:\/\/doi.org\/10.11607\/ofph.2031","journal-title":"J Oral Facial Pain Headache"},{"issue":"1","key":"5935_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40902-018-0159-z","volume":"40","author":"SY Kim","year":"2018","unstructured":"Kim SY, Kim YK, Yun PY, Bae JH (2018) Treatment of non-odontogenic orofacial pain using botulinum toxin-A: a retrospective case series study. Maxillofac Plast Reconstr Surg 40(1):21. https:\/\/doi.org\/10.1186\/s40902-018-0159-z","journal-title":"Maxillofac Plast Reconstr Surg"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-024-05935-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00784-024-05935-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-024-05935-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T14:02:32Z","timestamp":1729432952000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00784-024-05935-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,25]]},"references-count":33,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["5935"],"URL":"https:\/\/doi.org\/10.1007\/s00784-024-05935-5","relation":{},"ISSN":["1436-3771"],"issn-type":[{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,25]]},"assertion":[{"value":"17 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the were requested to sign an informed consent. All procedures were approved by the ethical committee of the University of Trieste (protocol code number 4, April 29th, 2024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"548"}}